Copyright
©The Author(s) 2015.
World J Clin Infect Dis. Nov 25, 2015; 5(4): 55-58
Published online Nov 25, 2015. doi: 10.5495/wjcid.v5.i4.55
Published online Nov 25, 2015. doi: 10.5495/wjcid.v5.i4.55
Figure 1 Pros and cons of empirical antifungal treatment.
Figure 2 Use of biomarkers to deescalate antifungal treatment.
AFT: Antifungal treatment; D: Day.
- Citation: Rouzé A, Jaffal K, Nseir S. How could we reduce antifungal use in the intensive care unit? World J Clin Infect Dis 2015; 5(4): 55-58
- URL: https://www.wjgnet.com/2220-3176/full/v5/i4/55.htm
- DOI: https://dx.doi.org/10.5495/wjcid.v5.i4.55